kickbacks

Insys to Pay $225M to Settle Painkiller Probes
Risk & Compliance

Insys to Pay $225M to Settle Painkiller Probes

The maker of the fentanyl spray Subsys "is being held responsible for its role in fueling the opioid epidemic," a prosecutor says.
By Matthew Heller | June 10, 2019
Read More
Petrobras Fined $1.8B for Duping U.S. Investors
Risk & Compliance

Petrobras Fined $1.8B for Duping U.S. Investors

U.S. authorities say the Brazilian energy giant padded its financial statements to conceal the payment of kickbacks to company executives by contractors.
By Matthew Heller | September 27, 2018
Read More
Former iPayment Execs Charged With $11M Fraud
Risk & Compliance

Former iPayment Execs Charged With $11M Fraud

Ex-employees Nasir Shakouri and Robert Torino allegedly embezzled funds through phony expense reimbursements, inflated invoices, and other improper actions.
By Matthew Heller | March 15, 2017
Read More
Ex-Valeant, Philidor Execs Accused of Kickback Scheme
Risk & Compliance

Ex-Valeant, Philidor Execs Accused of Kickback Scheme

The defendants “illegally converted Valeant shareholder money into their own personal nest eggs," a federal prosecutor alleges.
By Matthew Heller | November 18, 2016
Read More
Tenet Settles Kickback Charges for $513M
Risk & Compliance

Tenet Settles Kickback Charges for $513M

The hospital chain allegedly obtained $145 million in Medicaid and Medicare funds by paying an operator of prenatal clinics for referrals.
By Matthew Heller | October 4, 2016
Read More
Nine Charged in $131M Stock Fraud Scheme
Risk & Compliance

Nine Charged in $131M Stock Fraud Scheme

ForceField Energy's ex-chairman allegedly paid a publisher and others to hype its stock in exchange for kickbacks they did not disclose.
By Matthew Heller | May 4, 2016
Read More
Olympus Fined $623M Over Bribery Scheme
Risk & Compliance

Olympus Fined $623M Over Bribery Scheme

The medical device maker was accused of paying bribes and kickbacks to doctors and hospital administrators to win new business.
By Matthew Heller | March 2, 2016
Read More
Novartis Settles Kickback Charges for $370M
Risk & Compliance

Novartis Settles Kickback Charges for $370M

The Swiss drug maker allegedly turned specialty pharmacies into a "biased sales force" for its medications.
By Matthew Heller | November 20, 2015
Read More